La de Modena sacó datos efectivos para mayores el día 30 de septiembre. De la de Pfizer creo que no hay nada. La comparo porque las dos son de ARN.(Yo no seré de las primeras en ponérmela...)
There is no information yet on whether the vaccine prevents severe cases, the type that can cause hospitalization and death.
Nor is there any information yet on whether it prevents people from carrying the virus that causes Covid-19, SARS-CoV-2, without symptoms.
Because the vaccine has been studied for only a matter of months, it is impossible to say how long it will protect against infection with the virus. The vaccine does cause side effects, including aches and fevers, according to previously published data.
Instead, they planned to conduct the analysis after 62 cases. But by the time the plan had been formalized, there had been 94 cases of Covid-19 in the study. It’s not known how many were in the vaccine arm, but it would have to be nine or fewer.
In keeping with guidance from the Food and Drug Administration, the companies will not file for an emergency use authorization to distribute the vaccine until they reach another milestone: when half of the patients in their study have been observed for any safety issues for at least two months following their second dose. Pfizer expects to cross that threshold in the third week of November.
The FDA has granted Fast Track Designation to Novavax's (NASDAQ:NVAX)COVID-19 vaccine candidate, NVX-CoV2373.Fast Track status provides for more frequent interaction with the FDA review team and a rolling review of the marketing application.The company expects to begin its Phase 3 clinical trial in the U.S. and Mexico by the end of November.Novavax's ongoing Phase 3 trial of NVX-CoV2373 in the UK is expected to be fully enrolled by the end of November. Interim data are expected as soon as early Q1 2021.NVAX has secured $2B in funding for its global coronavirus vaccine program.
Después de los datos del otro día, voy a esperarlas un poco más abajo otra vez. Y si se van, mala suerte. Fuera: 15,39
#125264
Re: Farmas USA
Nueva entrada en rebajas en la que va como un pep-INO para abajo. Aguantando TLRY, puff con los del fumeque! Que baje a 9. Edito: Día muy raro. Cosas que suben un 20 y otras que lo bajan. Ya veremos si como hoy.
